Posts in tag

PBS listing


Positive funding recommendation for Mounjaro came with “unviable and unsustainable conditions”, sponsor says  Eli Lilly is calling for “wholesale changes” to be made to the PBS (Pharmaceutical Benefits Scheme) after withdrawing its application …

Resounding support for subsidising GLP-1s for obesity treatment, PBS public consultation submissions show, with quality of medicines issues present Submissions from 491 consumers, 25 health professionals and 23 organisations to …

PBAC recommends “risk sharing arrangement” to fund PBS listing of Wegovy for established cardiovascular disease with obesity  Pricing could be key for Novo Nordisk to get Wegovy (semaglutide) listed on …

Manufacturer calls for reform of Health Technology Assessment after dropping application to list an eczema treatment on the PBS  Pfizer withdraws application to list Cibinqo (abrocitinib) on the Pharmaceutical Benefits …

PBAC to consider semaglutide listing for new indication of established CVD with obesity The PBAC will soon consider whether Novo Nordisk’s Wegovy (semaglutide 2.4mg) should be subsidised for Australians with …

Health minister acknowledges cost barriers for patients seeking medicinal cannabis, but says the government has no control over prices suppliers charge  Patients prescribed medicinal cannabis are being urged to seek …

Eczema patients gifted with continued PBS listing of treatment after higher-than-expected demand nearly saw it withdrawn from the PBS Eczema support groups are praising the decision to keep a treatment …

First new treatment for endometriosis to be added to the PBS in three decades Dienogest (Visanne) is now listed on the PBS for the first time to treat endometriosis from …

PBAC recommends PBS listing of drug to treat endometriosis pain, noting need for new treatments for the condition The PBAC has recommended PBS listing of Ryeqo for treatment of moderate …

A new pre-filled autoinjector for at-home administration of mepolizumab will be reimbursed by the PBS from 1 June Patients with severe refractory eosinophilic asthma can now choose to receive treatment …

The government has announced a $48 million investment to list new treatments for lymphoma and multiple myeloma on the PBS This investment will save families up to $100,000 a year, …

A biodegradable implant to help with eye disease has been added to the PBS, for patients who are intolerant or resistant to systemic corticosteroids Ozurdex (dexamethasone 700µg) sustained-release intravitreal implant …